CoChat

Uric acid as a risk factor for cardiovascular disease

Open access
Waring, W.S. · 2000 · QJM
Cited by 121

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Over recent years there has been renewed debate about the nature of the association between raised serum uric acid concentration and cardiovascular disease.1 Several large studies have identified the value, in populations, of serum uric acid concentration in predicting the risk of cardiovascular events, such as myocardial infarction. This has directed research towards the potential mechanisms by which uric acid might have direct or indirect effects on the cardiovascular system. It has been difficult to identify the specific role of elevated serum uric acid because of its association with established cardiovascular risk factors such as hypertension, diabetes mellitus, hyperlipidaemia and obesity.2,3 Indeed, it is not even clear at this stage whether uric acid has a damaging or protective effect in these circumstances. Increased understanding of the mechanisms underlying these associations may allow a clearer interpretation of the importance of elevated serum uric acid concentrations, and the potential value of specific urate‐lowering treatment on cardiovascular disease. Purines arise from metabolism of dietary and endogenous nucleic acids, and are degraded ultimately to uric acid in man, through the action of the enzyme xanthine oxidase (Figure 1). Uric acid is a weak acid (pKa 5.8), distributed throughout the extracellular fluid compartment as sodium urate, and cleared from the plasma by glomerular filtration.4 Around 90% of filtered uric acid is reabsorbed from the proximal renal tubule, while active secretion into the distal tubule by an ATPase‐dependent mechanism contributes to overall clearance.5 Serum uric acid concentration within the population has a Gaussian distribution, with a typical reference range (95% CI) of 120–420 μmol/l. For an individual, urate concentration is determined by a combination of the rate of purine metabolism (both endogenous and exogenous) and the efficiency of renal clearance. Purine metabolism is influenced by dietary, as well as genetic factors regulating cell turnover. Uric acid is sparingly soluble in aqueous media, and persistent exposure to high serum levels predisposes to urate crystal deposition within soft tissues.4 All species apart from man and higher apes express urate oxidase, an enzyme responsible for further metabolism of uric acid to allantoin (a more soluble waste product) prior to excretion.6 In man, the urate oxidase gene located on chromosome 1 is not expressed due to two non‐sense mutations.7 Loss of uric oxidase activity appears to have developed under evolutionary pressure,7 suggesting that higher serum uric acid concentrations, or reduced urate oxidase may confer important advantages in man. Adenosine release is increased during hypoxia, and its local vasodilatating action may preserve blood flow and prevent tissue ischaemia. Uric acid is the end‐product of purine metabolism in man, whereas other species express uric oxidase, responsible for conversion of uric acid to more soluble excretory products. An epidemiological link between elevated serum uric acid and an increased cardiovascular risk has been recognized for many years.8,9 Observational studies show that serum uric acid concentrations are higher in patients with established coronary heart disease compared with healthy controls.10 Elevated serum uric acid concentrations are also found in healthy offspring of parents with coronary artery disease, indicating a possible causal relationship.2 However, hyperuricaemia is also associated with possible confounding factors including elevated serum triglyceride and cholesterol concentrations, blood glucose, fasting and post‐carbohydrate plasma insulin concentrations, waist‐hip ratio and body mass index.3,8,11,12 About one quarter of hypertensive patients have co‐existent hyperuricaemia13 and, interestingly, asymptomatic hyperuricaemia predicts future development of hypertension, irrespective of renal function.14 Among patients with established hypertension, elevated serum uric acid concentration has been associated with a significantly increased cardiovascular risk during a mean 6.6‐year follow‐up period.15 The proportional hazard ratio for one SD elevation of uric acid (29.2 μmol/l) was 1.22 (95%CI 1.11–1.35), which was higher than for one S.D. elevation of blood glucose (1.10, 95%CI 1.02–1.19), cholesterol (1.18, 95%CI 1.09–1.29) or systolic blood pressure (1.09, 95%CI 1.00–1.19). Thiazide diuretics confer unequivocal benefits in treatment of hypertensive patients, and cause a significant reduction in cardiovascular and all‐cause mortality.16 Persistence of the relationship between elevated serum uric acid concentration and increased cardiovascular risk among thiazide‐treated patients has prompted speculation that uric acid elevation may attenuate some of their potential benefits.17 Indeed, the US National Health and Nutrition Survey (NHANES) III showed that age‐adjusted rates of myocardial infarction and stroke are higher across increasing serum uric a

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/qjmed/93.11.707

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 121

Metadata

Authors
Waring, W. S.
Venue
QJM
Published
2000-11-01
Volume
93
Issue
11
Pages
707-713
ISSN
  • 0033-5622 (ISSN-L)
  • 1460-2393
OpenAlex
W1978224152
Cited by
121
References
3
FWCI
1.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Uric acid as a risk factor for cardiovascular disease. https://app.cochat.ai/papers/10.1093/qjmed/93.11.707
The paper
Waring, W. S. (2000). Uric acid as a risk factor for cardiovascular disease. QJM. https://doi.org/10.1093/qjmed/93.11.707

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.